On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its prequalification list. The vaccine, MVA-BN, is manufactured by Bavarian Nordic A/S. Prequalification is a mechanism “used to evaluate quality, safety and efficacy of medical products, such as vaccines ….
